Forte Biosciences's total assets for Q2 2025 were $107.78M, an increase of 127.11% from the previous quarter. FBRX total liabilities were $9.17M for the fiscal quarter, a 1.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.